Anesthesiologist Assistant in Connecticut Medicare Details, Address, Contact
6 Anesthesiologist Assistant nurses found. Showing 1 - 6
 Sara Titus, CRNA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Saint Vincents Medical Center, Bridgeport, CT 06606 Phone: 203-929-7353 Fax: 203-929-0756 |
Elizabeth Ann Kolthay, CRNA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7118 |
Alana Green, CRNA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2 Trap Falls Rd, Suite 414, Shelton, CT 06484 Phone: 203-929-7353 Fax: 203-929-0756 |
Ling Chow, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 7365 Main St, Suite 310, Stratford, CT 06614 Phone: 203-384-3072 |
 Josh A Yoffe, CRNA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 7365 Main St, Suite 310, Stratford, CT 06614 Phone: 203-384-3174 Fax: 203-384-4619 |
Carly Brueggestrat, CRNA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 7365 Main St, Stratford, CT 06614 Phone: 203-384-3174 Fax: 203-384-4619 |
News Archive
New approach to address the shortage of personal protective equipment
Due to the rapid spread of COVID-19, there is an increasing shortage of personal protective equipment (PPE) crucial to protecting health care workers from infection.
Life expectancy for Spaniards increases due to 'cardiovascular revolution'
Over the last century, life expectancy for Spaniards has increased by 40 years. A study by the International University of La Rioja highlights the main cause, since 1980, as being the reduced incidence of cardiovascular diseases while other pathologies, such as mental illnesses and certain types of cancer, have been seen to rise. The authors predict that the effects of the economic recession on mortality will show up in the long-term.
Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.
Novartis' Afinitor decreases size of SEGAs associated with tuberous sclerosis
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
Study revolutionizes treatment principles for functional mitral regurgitation
For years now, cardiology experts have been arguing about how to determine the degree of severity in patients with functional mitral regurgitation and, hence, to assess when it is necessary to operate on the valve.
› Verified 8 days ago